BioAegis Therapeutics receives approval to proceed with phase 2 trial of its gelsolin Covid-19 treatment

This article was originally published here

BioAegis expects to recruit its first patient and begin the study shortly at Hospital Universitari Sant Joan de Reus in Tarragona, Spain. Clinical Protocol for Phase 2 Clinical

The post BioAegis Therapeutics receives approval to proceed with phase 2 trial of its gelsolin Covid-19 treatment appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply